Quality Research on Eye Drops for National Drug Sampling Inspection

OBJECTIVE To evaluate the current quality status and existing quality risks of domestic eye drops sampling, and provide suggestions for improvement.

METHODS Reviewing the current status of sampling quality of eye drops across the country over the years, and in accordance with the overall requirements of the national evaluative sampling plan, using legal standard inspection methods combined with exploratory research to inspect samples in 2018, 2020 and 2021, and analyzing the main quality problems discovered.

RESULTS The pass rate of eye drops sampling inspections had shown an improving trend year by year, but research had found that there were still certain problems in quality standards, prescription design, production technology, and packaging material compatibility.

CONCLUSION  At present, eye drops still have problems such as unreasonable prescriptions and substandard bacteriostatic efficacy of some products. It is recommended to improve and unify quality standards, optimize prescriptions and packaging materials, and standardize product labels.